Abstract
Background/aimsTo use a composite endpoint scoring system in assessing efficacy of two doses of intravenous tocilizumab (TCZ), in eyes with non-infectious uveitis.MethodsData from STOP-Uveitis Study (a phase 2 multicentre, randomised,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have